|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/7068 | |
| A61K 31/7072 | |||
| A61P 35/00 |
| (11) | Patento numeris | 1491201 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04023557.4 |
| Europos patento paraiškos padavimo data | 1996-06-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-12-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2006-03-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 472210 | 1995-06-07 | US |
| (72) |
Vonborstel, Reid W., US
Bamat, Michael K., US
|
| (73) |
Wellstat Therapeutics Corporation,
930 Clopper Road, Gaithersburg, MD 20878,
US
|
| (54) | Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides |
| Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides |